Skip Navigation

Noticias

  • Imprimir
  • Comentar

Fiji seaweed may help fight malaria

Fuente: Science Now

24 febrero 2011 | EN

Callophycus serratus seaweed

Researchers plan to test the seaweed compounds in mice next

Julia Kubanek

A seaweed found in Fiji is a promising source of a possible new antimalarial drug, researchers reported at the annual meeting of the American Association for the Advancement of Sciences, in Washington, United States, this week.

The red algae, Callophycus serratus, produce a compound which can kill the malaria parasite, said Julia Kubanek, a chemical ecologist at Georgia Institute of Technology, Atlanta.

If it proves to work in humans it could be added to the arsenal of drugs to fight the malaria parasite. Reports of resistance to the latest drug, artemisinin have already been reported in Cambodia.

In a search for natural antibiotics, Kubanek and her colleagues collected fistfuls of seaweed and other marine species, isolating compounds and screening them for antibiotic and other biomedical properties. They found that the red algae produce a family of unusual anti-fungal, ring-shaped compounds called bromophycolides, and one of those has strong antimalarial properties.

The next step for the team is to test the compound in mice.

Link to full article in Science Now

AGREGUE SU COMENTARIO

Esta es su red: comparta sus opiniones sobre cualquiera de nuestros artículos agregando sus comentarios.

Usted debe registrarse para enviar un comentario o para escribir a un autor que haya aceptado recibir comentarios. Por favor entrarsuscribirse.

Todos los comentarios están sujetos a revisión. Nos reservamos el derecho de editar los comentarios que contengan un lenguaje inapropiado o inadecuado. SciDev.Net mantiene los derechos de autor de todo el material que se publica en el portal. Por favor lea las condiciones de uso para más detalles.

Todo el material de SciDev.Net se puede reproducir gratuitamente siempre que se de crédito a la fuente y al autor. Para más detalles ver Creative commons.

Volver Noticias
Subir